Condensed Consolidated Balance Sheets - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 1,155,349 | $ 3,662,615 |
Accounts receivable | 219,618 | |
Other assets | 117,728 | 43,391 |
Total current assets | 1,492,695 | 3,706,006 |
Long-term assets | ||
Property and equipment - net | 220,765 | 206,810 |
Deferred compensation | 416,666 | |
Right of use asset - operating | 460,705 | 544,670 |
Security deposit | 17,004 | 17,004 |
Total long-term assets | 698,474 | 1,185,150 |
Total assets | 2,191,169 | 4,891,156 |
Current liabilities | ||
Accounts payable | 249,880 | 195,381 |
Notes payable | 738,985 | 1,000,001 |
Notes payable CARES Act PPP Loan | 24,189 | |
Due to related parties | 50,000 | 50,000 |
Operating lease liability - current | 104,117 | 76,227 |
Accrued expenses | 10,807 | 21,870 |
Accrued dividends | 48,079 | 48,079 |
Subscription payable | 585,000 | |
Total current liabilities | 1,786,868 | 1,415,747 |
Long-term liabilities | ||
Operating lease liability - non-current | 425,339 | 507,188 |
Total long-term liabilities | 425,339 | 507,188 |
Total liabilities | 2,212,207 | 1,922,935 |
Stockholders’ Equity (Deficit) | ||
Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at September 30, 2022 and December 31, 2021 (Liquidation preference $340,050 and $340,050, respectively) | 14 | 14 |
Common stock, $.001 par value, 500,000,000 shares authorized; 207,817,878 and 207,562,461 shares issued and outstanding at September 30, 2022 and at December 31, 2021, respectively | 207,817 | 207,562 |
Additional paid-in capital | 101,728,483 | 100,452,862 |
Accumulated deficit | (101,957,353) | (97,692,217) |
Total Stockholders’ Equity (Deficit) | (21,038) | 2,968,221 |
Total Liabilities and Stockholders’ Equity (Deficit) | $ 2,191,169 | $ 4,891,156 |